Too much sunshine: is there a negative side to Open Payments?

“We want our doctors … to rely on evidence that is real and true and accurate and not partial or affected some way by a money interest behind it.” — Senator Charles Grassley[1] Even before the passage of the Physician Payments Sunshine provisions (a.k.a. Open Payments), politicians and other policy advocates have regaled us with the need for physician payment transparency in life sciences.  They have argued among other things that…

Conflict of Interest Reporting Improves Among IRB Members According to JAMA Internal Medicine Study

I wonder to what extent these results will further changes to the Open Payments regulations? What do others think?  Link to full article

Intent to Exempt Certain Unclassified, Class II, and Class I Reserved Medical Devices from Premarket Notification Requirements

It seems that FDA intends to exempt certain unclassified medical devices, certain Class II medical devices, and certain Class I medical devices that are subject to the reserved criteria of section 510(l) from premarket notification requirements. It is certainly a step in the right direction.  Link to guidance document